Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,564,500
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
22,400,142
-
Shares change
-
+728,802
-
Total reported value, excl. options
-
$479,016,785
-
Value change
-
+$15,346,848
-
Number of buys
-
39
-
Number of sells
-
-25
-
Price
-
$21.39
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q3 2016
79 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q3 2016.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,400,142 shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (5,359,632 shares), FMR LLC (3,534,403 shares), Redmile Group, LLC (2,021,617 shares), Arrowpoint Asset Management, LLC (1,320,327 shares), BRIDGER MANAGEMENT, LLC (996,076 shares), EAGLE ASSET MANAGEMENT INC (980,673 shares), BlackRock Fund Advisors (976,087 shares), UBS ASSET MANAGEMENT AMERICAS INC (852,815 shares), VANGUARD GROUP INC (701,040 shares), and Neuberger Berman Group LLC (688,715 shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.